The global demand for Parenteral Packaging Market is presumed to reach the market size of nearly USD 25.89 Billion by 2032 from USD 10.21 Billion in 2023 with a CAGR of 10.89% under the study period 2024 - 2032.
Parenteral packaging refers to the materials and containers used for the sterile packaging injectable drugs, fluids, and solutions intended for administration via routes other than the digestive tract, such as intravenous, intramuscular, or subcutaneous injection. These packaging systems must maintain the sterility, integrity, and stability of the pharmaceutical product throughout its shelf life, protecting it from contamination, light exposure, and physical damage. Common parenteral packaging materials include glass vials, ampules, syringes, and pre-filled cartridges, as well as plastic containers and bags made from materials such as polypropylene, polyethylene, and cyclic olefin copolymer (COC).
MARKET DYNAMICS
The growing prevalence of chronic diseases, aging populations, and advancements in biopharmaceuticals drive the demand for parenteral medications administered via injection routes such as subcutaneous (SC) injections and intravenous (IV). With rising healthcare expenditures, expanding patient populations, and the increasing adoption of injectable therapies for cancer, diabetes, autoimmune diseases, and infectious diseases, there is a growing need for parenteral packaging solutions that ensure product integrity, compatibility, and patient safety throughout the drug lifecycle. Additionally, advancements in packaging materials, container closure systems, and sterile manufacturing processes enable the development of parenteral packaging solutions that offer barrier protection, microbial stability, and tamper-evident features to maintain drug potency, stability, and sterility during storage, transportation, and administration.
Moreover, the increasing emphasis on patient-centric packaging, user-friendly designs, and compliance packaging drives market innovation as pharmaceutical companies seek packaging solutions that enhance medication adherence, facilitate self-administration, and improve patient outcomes. Furthermore, regulatory requirements, quality standards, and industry guidelines for parenteral packagings, such as USP <797>, USP <800>, and ISO 13485, drive market compliance, quality assurance, and product differentiation as manufacturers strive to meet regulatory expectations, mitigate risks, and maintain product safety and efficacy. However, stringent regulatory requirements, safety standards, and compliance issues may hamper market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of parenteral packaging. The growth and trends of parenteral packaging industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the parenteral packaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Material Type
Plastic (PVC, Polyolefin)
Glass
By Packaging Type
Small-Volume Parenteral
Large-Volume Parenteral
By Product Type
Bags
Ampoules
Vials
Prefilled Syringes & Cartridges
Ready-To-Mix Systems
By End User
Pharmaceutical Manufacturers
Hospitals
Dispensaries
Clinics
Ambulatory Services
Contract Research Organization
Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Parenteral Packaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Packaging market include RPC Group, Unilife Corporation, Gerresheimer AG, Stevanato Group, Berry Plastics Corporation, Nipro Corporation, MeadWestvaco Corporation, Becton Dickinson and Company Inc., Schott AG, Dickinson and Company Inc., Ypsomed Holding AG, Terumo Corporation, SiO2 Medical Products, West Pharmaceutical Services, Schott Pharmaceuticals Services Inc., Owens-Illinois, Graphic Packaging Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.1 Market Attractiveness Analysis By Material Type
3.7.2 Market Attractiveness Analysis By Packaging Type
3.7.3 Market Attractiveness Analysis By Product type
3.7.4 Market Attractiveness Analysis By End User
3.7.5 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL PARENTERAL PACKAGING MARKET ANALYSIS BY MATERIAL TYPE
5.1. Overview By Material Type
5.2. Historical and Forecast Data
5.3. Analysis By Material Type
5.4. Plastic (PVC, Polyolefin) Historic and Forecast Sales By Regions
5.5. Glass Historic and Forecast Sales By Regions
6. GLOBAL PARENTERAL PACKAGING MARKET ANALYSIS BY PACKAGING TYPE
6.1. Overview By Packaging Type
6.2. Historical and Forecast Data
6.3. Analysis By Packaging Type
6.4. Small-Volume Parenteral Historic and Forecast Sales By Regions
6.5. Large-Volume Parenteral Historic and Forecast Sales By Regions
7. GLOBAL PARENTERAL PACKAGING MARKET ANALYSIS BY PRODUCT TYPE
7.1. Overview By Product type
7.2. Historical and Forecast Data
7.3. Analysis By Product type
7.4. Bags Historic and Forecast Sales By Regions
7.5. Ampoules Historic and Forecast Sales By Regions
7.6. Vials Historic and Forecast Sales By Regions
7.7. Prefilled syringes & Cartridges Historic and Forecast Sales By Regions
7.8. Ready-to-mix Systems Historic and Forecast Sales By Regions
8. GLOBAL PARENTERAL PACKAGING MARKET ANALYSIS BY END USER
8.1. Overview By End User
8.2. Historical and Forecast Data
8.3. Analysis By End User
8.4. Pharmaceutical Manufacturers Historic and Forecast Sales By Regions
8.5. Hospitals Historic and Forecast Sales By Regions
8.6. Dispensaries Historic and Forecast Sales By Regions
8.7. Clinics Historic and Forecast Sales By Regions
8.8. Ambulatory Services Historic and Forecast Sales By Regions
8.9. Contract Research Organization Historic and Forecast Sales By Regions
8.10. Others Historic and Forecast Sales By Regions
9. GLOBAL PARENTERAL PACKAGING MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
9.3.1 Overview, Historic and Forecast Data Sales Analysis
9.3.2 North America By Segment Sales Analysis
9.3.3 North America By Country Sales Analysis
9.3.4 United States Sales Analysis
9.3.5 Canada Sales Analysis
9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
9.4.1 Overview, Historic and Forecast Data Sales Analysis
9.4.2 Europe By Segment Sales Analysis
9.4.3 Europe By Country Sales Analysis
9.4.4 United Kingdom Sales Analysis
9.4.5 France Sales Analysis
9.4.6 Germany Sales Analysis
9.4.7 Italy Sales Analysis
9.4.8 Russia Sales Analysis
9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
9.5.1 Overview, Historic and Forecast Data Sales Analysis
9.5.2 Asia Pacific By Segment Sales Analysis
9.5.3 Asia Pacific By Country Sales Analysis
9.5.4 China Sales Analysis
9.5.5 India Sales Analysis
9.5.6 Japan Sales Analysis
9.5.7 South Korea Sales Analysis
9.5.8 Australia Sales Analysis
9.5.9 South East Asia Sales Analysis
9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
9.6.1 Overview, Historic and Forecast Data Sales Analysis
9.6.2 Latin America By Segment Sales Analysis
9.6.3 Latin America By Country Sales Analysis
9.6.4 Brazil Sales Analysis
9.6.5 Argentina Sales Analysis
9.6.6 Peru Sales Analysis
9.6.7 Chile Sales Analysis
9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
9.7.1 Overview, Historic and Forecast Data Sales Analysis
9.7.2 Middle East & Africa By Segment Sales Analysis
9.7.3 Middle East & Africa By Country Sales Analysis
9.7.4 Saudi Arabia Sales Analysis
9.7.5 UAE Sales Analysis
9.7.6 Israel Sales Analysis
9.7.7 South Africa Sales Analysis
9.7.8 Rest Of Middle East And Africa Sales Analysis
10. COMPETITIVE LANDSCAPE OF THE PARENTERAL PACKAGING COMPANIES
10.1. Parenteral Packaging Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11. COMPANY PROFILES OF PARENTERAL PACKAGING INDUSTRY
11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. RPC Group
11.3.1 Company Overview
11.3.2 Company Revenue
11.3.3 Products
11.3.4 Recent Developments
11.4. Unilife Corporation
11.4.1 Company Overview
11.4.2 Company Revenue
11.4.3 Products
11.4.4 Recent Developments
11.5. Gerresheimer AG
11.5.1 Company Overview
11.5.2 Company Revenue
11.5.3 Products
11.5.4 Recent Developments
11.6. Stevanato Group
11.6.1 Company Overview
11.6.2 Company Revenue
11.6.3 Products
11.6.4 Recent Developments
11.7. Berry Plastics Corporation
11.7.1 Company Overview
11.7.2 Company Revenue
11.7.3 Products
11.7.4 Recent Developments
11.8. Nipro Corporation
11.8.1 Company Overview
11.8.2 Company Revenue
11.8.3 Products
11.8.4 Recent Developments
11.9. MeadWestvaco Corporation
11.9.1 Company Overview
11.9.2 Company Revenue
11.9.3 Products
11.9.4 Recent Developments
11.10. Becton Dickinson And Company Inc.
11.10.1 Company Overview
11.10.2 Company Revenue
11.10.3 Products
11.10.4 Recent Developments
11.11. Schott AG
11.11.1 Company Overview
11.11.2 Company Revenue
11.11.3 Products
11.11.4 Recent Developments
11.12. Dickinson And Company Inc.
11.12.1 Company Overview
11.12.2 Company Revenue
11.12.3 Products
11.12.4 Recent Developments
11.13. Ypsomed Holding AG
11.13.1 Company Overview
11.13.2 Company Revenue
11.13.3 Products
11.13.4 Recent Developments
11.14. Terumo Corporation
11.14.1 Company Overview
11.14.2 Company Revenue
11.14.3 Products
11.14.4 Recent Developments
11.15. SiO2 Medical Products
11.15.1 Company Overview
11.15.2 Company Revenue
11.15.3 Products
11.15.4 Recent Developments
11.16. West Pharmaceutical Services
11.16.1 Company Overview
11.16.2 Company Revenue
11.16.3 Products
11.16.4 Recent Developments
11.17. Schott Pharmaceuticals Services Inc.
11.17.1 Company Overview
11.17.2 Company Revenue
11.17.3 Products
11.17.4 Recent Developments
11.18. Owens-Illinois
11.18.1 Company Overview
11.18.2 Company Revenue
11.18.3 Products
11.18.4 Recent Developments
11.19. Graphic Packaging Group.
11.19.1 Company Overview
11.19.2 Company Revenue
11.19.3 Products
11.19.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies